Fig. 4From: Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial(a) Overall survival according to response (b) Overall survival according to responder or non-responder statusBack to article page